UPDATE 3-Indonesia turns to China for more vaccines after AstraZeneca delays

Indonesia is in talks with China to secure as many as 100 million COVID-19 vaccine doses to plug a gap in deliveries after delays in arrivals of AstraZeneca shots, the health minister said on Thursday.

Reuters | Jakarta | Updated: 09-04-2021 09:57 IST | Created: 09-04-2021 09:32 IST
UPDATE 3-Indonesia turns to China for more vaccines after AstraZeneca delays
Representative Image Image Credit: ANI

Indonesia is in talks with China to secure as many as 100 million COVID-19 vaccine doses to plug a gap in deliveries after delays in arrivals of AstraZeneca shots, the health minister said on Thursday. Indonesia would receive 20 million doses of the AstraZeneca vaccine via a bilateral deal in 2021, instead of 50 million initially agreed, Health Minister Budi Gunadi Sadikin told a parliamentary hearing.

The remaining 30 million doses were due to be shipped by the second quarter of 2022, he said. Budi said the government had "embarked on a discussion with the Chinese government to ask for an additional 90-100 million (doses)".

"We're also asking for vaccines from the U.S. when they're done with their own vaccinations and sell their vaccines overseas." Besides AstraZeneca, Indonesia relies heavily on vaccines produced by China's Sinovac Biotech for inoculations which began in January. It aims to reach 181.5 million people within a year in a bid to reach herd immunity.

Sinovac has supplied about 56 million doses so far. Indonesia was also due to receive 54 million doses of the AstraZeneca vaccine in phases via the COVAX sharing scheme, though Budi said Indian export restrictions would delay shipments in April.

"That's something that we cannot accept and we're negotiating with AstraZeneca. So that's 100 million doses of vaccine whose schedule remains unclear," he said. In response, AstraZeneca Indonesia referred Reuters to an April 2 statement in which the company said it aimed to start first deliveries in June.

Indonesia has also launched a private vaccination program for companies to buy government-procured vaccines for their staff. State-owned company Bio Farma had started negotiations with China's Sinopharm and Cansino, along with the producer of Russia's Sputnik V, for vaccines for the private program, Bio Farma chief executive Honesti Basyir told the parliamentary hearing.

The Southeast Asian country has been struggling to control one of Asia's worst epidemics, with 1.55 million cases and 42,200 deaths. It has administered at least one vaccine shot to more than 9.22 million people. European and British regulators said on Wednesday they had found possible links between AstraZeneca's vaccine and very rare cases of blood clots, but reaffirmed the vaccine's importance in protecting people against COVID-19.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...

Privacy and data protection: Reviewing notable policy frameworks

The evolved privacy principles and the resulting legislation across the world primarily aim to force the data collector to define the purpose for which the data is being collected along with the need to obtain explicit consent for the said ...

Videos

Latest News

Xavi Hernandez leads Al-Sadd into Asian Champions League

Xavi Hernandez was touted as a future coach of Barcelona even before leading Al-Sadd to the Qatar league title undefeated earlier this month. His chances will only improve if he can add the Asian Champions League title to his accomplishment...

COVID-19: Delhi's Kalkaji Temple to regulate number of devotees during Navratri through e-passes

In an effort to restrict the number of visitors amid rising COVID-19 numbers, the Kalkaji Temple in the national capital has introduced e-passes for the entry of devotees on the occasion of the Navratri. Elaborating on the newly-introduced ...

Punjab Kings is not for the light-hearted, says Rahul after thrilling win against RR

After registering a thrilling four-run victory over the Rajasthan Royals, Punjab Kings skipper KL Rahul said that his team is not for the light-hearted as they have a knack of producing nail-bitters. Sanju Samsons fighting hundred went in v...

Report: Manchester United looks to buy Australian team

Manchester United is reported to be interested in joining its English Premier League city rival and become a team owner Down Under in the A-League, although the chief executive of the Australian club is calling it nothing more than speculat...

Give Feedback